Results 191 to 200 of about 63,047 (307)

Aberrant lipid metabolism renders an aggressive behavior of T-lymphoblastic lymphoma in a MASH model. [PDF]

open access: yesOncogene
Guo W   +8 more
europepmc   +1 more source

Extracorporeal Cytokine Hemadsorption for the Treatment of Severe Steroid Refractory Cytokine Release Syndrome Secondary to T‐Cell Immunotherapy for B‐Cell Malignancies: A Case Series

open access: yes
Hematological Oncology, Volume 44, Issue 4, July 2026.
Gianluca Cavallaro   +12 more
wiley   +1 more source

Reprogramming Antitumor Immunity: NK Cell Strategies to Navigate the Immunosuppressive Tumor Microenvironment

open access: yesAdvanced Science, Volume 13, Issue 35, 24 June 2026.
ABSTRACT Tumor immune escape is a major barrier to durable cancer immunotherapy, as advanced malignancies create a tumor microenvironment (TME) that preferentially exhausts and disables T cell responses. While most approved cell therapies are T cell‐based, this limitation motivates the exploration of an alternative effector cell platform.
Tereza Kochs   +4 more
wiley   +1 more source

Efficacy and Safety of Immune Checkpoint Inhibitors in the Treatment of Hematologic Malignancies: An Umbrella Review of Systematic Reviews and Meta‐Analyses

open access: yesCancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background This umbrella review summarizes evidence from systematic reviews and meta‐analyses on the efficacy and safety of immune checkpoint inhibitors (ICIs) in hematologic malignancies. To our knowledge, this is the first umbrella review to comprehensively evaluate ICIs across multiple hematologic cancers.
Zhengyu Yu   +6 more
wiley   +1 more source

Risk Factors Influencing Survival in T-Cell Lymphoblastic Lymphoma and T-Cell Acute Lymphoblastic Leukemia. [PDF]

open access: yesCancer Med
Kim TY   +12 more
europepmc   +1 more source

Cancer Prevalence Among Large Cohort of Individuals With Down Syndrome: Implications for Screening Guidelines

open access: yesCancer Medicine, Volume 15, Issue 6, June 2026.
Individuals with Down syndrome have distinctive cancer profiles as compared with the general US population. Healthcare guidelines related to cancer screenings should reflect these unique profiles. ABSTRACT Introduction It is known that individuals with Down syndrome (DS) have a significantly different spectrum of malignancies and neoplasms.
Veronica Fitzpatrick   +6 more
wiley   +1 more source

Descriptive Epidemiology and Prognosis of Pediatric Acute Leukemia in the Afro‐Descendant Population of the French West Indies and French Guiana

open access: yesCancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Introduction The epidemiology of acute leukemia (AL) in children in Afro‐descendant (AD) populations is poorly described, and survival is often considered worse in these populations. The aim of this study is to describe the epidemiology and prognosis of childhood AL in the AD population of the French West Indies/French Guiana (FWI/FG ...
Julie Mascle   +16 more
wiley   +1 more source

Paediatric lymphoblastic lymphoma: a national review of 20 years of clinical and biological data in Ireland. [PDF]

open access: yesAnn Hematol
Trinquand A   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy